{
  "LinkTitle": "D-2022-1588",
  "Status": "Initial",
  "InitialDMPReviewStatus": "Reviewed",
  "Funder": "IOF",
  "ProjectTitle": "Nanomaterial enhanced immunotherapy for tumor treatment.",
  "InitialFeedbackHistory": "17/05/2022\r\n6. The expectation is now for KU Leuven to be retained for 10 years (not 5).",
  "label": "good with suggestions"
}